BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2478705)

  • 1. Elevated maternal serum alpha-fetoprotein values. How low is high?
    Lenke RR; Guerrieri J; Nemes JM; Kurczynski TW; French B; Gray M; Schut H; Ashwood ER
    J Reprod Med; 1989 Aug; 34(8):511-6. PubMed ID: 2478705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early pregnancy screening for neural tube defects in Israel.
    Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
    Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
    Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
    J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
    J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
    Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extremely high maternal serum alpha-fetoprotein levels at second-trimester screening.
    Killam WP; Miller RC; Seeds JW
    Obstet Gynecol; 1991 Aug; 78(2):257-61. PubMed ID: 1712441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
    Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
    Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved reliability of a serum alpha-fetoprotein enzyme immunoassay compared with a radioimmunoassay.
    Peleg L; Slor H; Cordova T; Ayalon D; Legum C; Rudick A
    Isr J Med Sci; 1986; 22(3-4):215-9. PubMed ID: 2427476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-year results of routine alpha-fetoprotein testing on prenatal patients in a family practice.
    Weiss BD
    J Fam Pract; 1988 Mar; 26(3):273-80. PubMed ID: 2450166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of folic acid fortification in the United States: markedly diminished high maternal serum alpha-fetoprotein values.
    Evans MI; Llurba E; Landsberger EJ; O'Brien JE; Harrison HH
    Obstet Gynecol; 2004 Mar; 103(3):474-9. PubMed ID: 14990409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
    Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
    Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
    Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
    Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inadequacy of the current correction for maternal weight in maternal serum alpha-fetoprotein interpretation.
    Drugan A; Dvorin E; Johnson MP; Uhlmann WR; Evans MI
    Obstet Gynecol; 1989 Nov; 74(5):698-701. PubMed ID: 2478941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
    Grau P; Robinson L; Tabsh K; Crandall BF
    Obstet Gynecol; 1990 Dec; 76(6):1042-5. PubMed ID: 1700349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Fetoprotein screening.
    Burton BK
    Adv Pediatr; 1986; 33():181-96. PubMed ID: 2432763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.
    Doran TA; Valentine GH; Wong PY; Wielgosz G; Benzie RJ; Soltan HC; Jenner MR; Morland PA; Montgomery RJ; Allen LC
    CMAJ; 1987 Aug; 137(4):285-93. PubMed ID: 2440547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.